AMRI   1Q Revenues: $81.8 million (+38%) 1Q Loss: $2.2 million (earnings were $3.5 million in 1Q14) Comments: Contract revenue in the quarter was $75.1 million, up 47% driven by the Drug Product business, increased capacity utilization, and the benefit of cost reduction initiatives and facility optimization. Discovery and Development Services contract revenue was $19.3 million, up 1%. API contract revenue increased 27% to $37.8 million, which includes the addition of Cedarburg Pharmaceuticals....